Venetoclax + Azacitidine: what to expect, day by day
AML (Acute Myeloid Leukemia)28-day cycle8 effects documented
A gentler-than-intensive-chemo combination for AML, taken mostly at home after the start. The first few days use a careful venetoclax dose ramp-up (with bloodwork and fluids) to prevent tumor lysis. The main ongoing risks are low blood counts and infections; nausea, diarrhea, and tiredness are common too.
Oral venetoclax (daily) + azacitidine (injections, days 1-7) in 28-day cycles — for AML in people who can't have intensive chemo. A critical early step is the venetoclax dose RAMP-UP (100→200→400 mg over 3 days) done with close monitoring to prevent tumor lysis. Low blood counts and infections are the main ongoing risks.
Get help straight away — this is true on any regimen, on any day.
A temperature of 100.4°F (38°C) or higher during treatment can mean a
serious infection while your blood counts are low. Call your team or go to the ER — do not
wait it out.
Also urgent: trouble breathing or chest pain · swelling of the face, lips or throat ·
new confusion or fainting · shaking chills · not being able to keep fluids down.
This is standing guidance shown to everyone. Nothing on this page is based on anything
about you, and nobody is monitoring you.
Timed to the cycle
No effect in this record carries a day window that a retrievable
document supports for this regimen. That is a gap in the evidence, not a sign that nothing
happens — the effects below are still what is reported.
Not tied to a cycle day
These build with the number of doses, or are measured from when treatment started, so a cycle day would be the wrong shape for them. Each keeps the timing its own source states.
Tumor lysis syndrome (during ramp-up)
during the first-cycle dose ramp-up
As venetoclax rapidly kills leukemia cells, released salts can stress the kidneys and heart. The 3-day dose ramp-up exists specifically to prevent this — done with hydration, a uric-acid-lowering medicine, and frequent bloodwork (often in hospital or with close observation). With this approach it's now uncommon.
Call your team: Much less urine than usual, severe cramps, or a fast/irregular heartbeat during ramp-up.
severe in 1% · from Venetoclax
Neutropenia
A drop in infection-fighting white cells is very common and can be prolonged; your team checks counts and may pause or reduce venetoclax between cycles.
Call your team urgently: A temperature of 100.4°F (38.0°C) or higher — an emergency.
severe in 42% · from Venetoclax, Azacitidine
Febrile neutropenia
Fever while white cells are low — a medical emergency needing immediate antibiotics. Preventive antimicrobials are commonly used.
Call your team urgently: Fever with feeling unwell — go to the ER and say you're on chemotherapy.
severe in 42% · from Venetoclax, Azacitidine
Infections (incl. pneumonia)
Serious infections, including pneumonia, are common because of the low counts. Report fever, cough, or breathlessness promptly; take any preventive medicines as directed.
Call your team urgently: Fever, cough, or breathlessness — contact your team urgently.
severe in 64 (any infection); 20 (pneumonia)% · from Venetoclax, Azacitidine
Thrombocytopenia
A drop in platelets (which help blood clot). Watch for easy bruising or bleeding.
Call your team: Bleeding that won't stop, or black/tarry stools.
severe in 45% · from Venetoclax, Azacitidine
Nausea
Sickness in the first 24 hours is the "acute" phase and usually peaks 2-3 hours in; anything from 24 to 120 hours is the "delayed" phase.
Usually mild-moderate and controlled with anti-nausea medicine.
reported by about 44% of people · Timing from a clinical guideline · from Azacitidine, Venetoclax
Diarrhea / constipation
Bowel changes in either direction are common. Hydration, diet adjustments, and medicines as advised help.
reported by about 41 (diarrhea); 43 (constipation)% of people · from Venetoclax, Azacitidine
Fatigue
Tiredness is common, partly from low red cells. Pace activities and rest.
reported by about 21% of people; severe in 6% · from Venetoclax, Azacitidine
A window appears here only where a retrievable document ties it to a drug in
this regimen. Where nothing could be found, the window was removed rather than estimated —
so a missing time is an honest gap, not an oversight.